View in EDS HTML Full Text PDF Full Text

Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines.

Saved in:
Bibliographic Details
Title: Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines.
Authors: Luczkowiak J; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain., Rivas G; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain., Labiod N; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain., Lasala F; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain., Rolo M; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain., Lora-Tamayo J; Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain., Mancheno-Losa M; Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain., Rial-Crestelo D; Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain., Pérez-Rivilla A; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain., Folgueira MD; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain., Delgado R; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain.
Source: Journal of medical virology [J Med Virol] 2023 Jan; Vol. 95 (1), pp. e28268. Date of Electronic Publication: 2022 Nov 10.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36319593
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Luczkowiak+J%22">Luczkowiak J</searchLink>; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rivas+G%22">Rivas G</searchLink>; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Labiod+N%22">Labiod N</searchLink>; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lasala+F%22">Lasala F</searchLink>; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rolo+M%22">Rolo M</searchLink>; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lora-Tamayo+J%22">Lora-Tamayo J</searchLink>; Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mancheno-Losa+M%22">Mancheno-Losa M</searchLink>; Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Rial-Crestelo+D%22">Rial-Crestelo D</searchLink>; Department of Internal Medicine, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Pérez-Rivilla+A%22">Pérez-Rivilla A</searchLink>; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Folgueira+MD%22">Folgueira MD</searchLink>; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Delgado+R%22">Delgado R</searchLink>; Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.; Department of Microbiology, Hospital Universitario 12 de Octubre, Madrid, Spain.; CIBER de Enfermedades Infecciosas (CIBERINFEC - Instituto de Salud Carlos III), Madrid, Spain.; Department of Medicine, School of Medicine, Universidad Complutense, Madrid, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227705876%22">Journal of medical virology</searchLink> [J Med Virol] 2023 Jan; Vol. 95 (1), pp. e28268. <i>Date of Electronic Publication: </i>2022 Nov 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7705876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-9071 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201466615%22">01466615 </searchLink><i>NLM ISO Abbreviation: </i>J Med Virol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36319593
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jmv.28268
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e28268
    Titles:
      – TitleFull: Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Luczkowiak J
      – PersonEntity:
          Name:
            NameFull: Rivas G
      – PersonEntity:
          Name:
            NameFull: Labiod N
      – PersonEntity:
          Name:
            NameFull: Lasala F
      – PersonEntity:
          Name:
            NameFull: Rolo M
      – PersonEntity:
          Name:
            NameFull: Lora-Tamayo J
      – PersonEntity:
          Name:
            NameFull: Mancheno-Losa M
      – PersonEntity:
          Name:
            NameFull: Rial-Crestelo D
      – PersonEntity:
          Name:
            NameFull: Pérez-Rivilla A
      – PersonEntity:
          Name:
            NameFull: Folgueira MD
      – PersonEntity:
          Name:
            NameFull: Delgado R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2023 Jan
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1096-9071
          Numbering:
            – Type: volume
              Value: 95
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of medical virology
              Type: main
ResultId 1